The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
The European Innovation Council (EIC) has awarded nearly €116 million in funding to 31 new research projects selected through the 2024 EIC Pathfinder Challenges call.
The role of research and innovation in Europe, including the challenge COVID-19 brings to the sector, the principles of Open Access, increased cross-border collaboration plus gender and diversity, are discussed here.
Open Access Government looks into the National Institute of General Medical Sciences (NIGMS)’s Biochemistry and Bio-related Chemistry Branch, and its current research areas and priorities.
Here, Open Access Government maps out Switzerland’s research funding plans in 2020 onwards to maintain its position as a world leader in research, innovation, and education.
Researchers from the University of North Carolina and NC State have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise, leading the way for new diabetes treatment.
Dr Carlos Ziebert, Head of IAM-AWP’s Calorimeter Center, KIT, presents a holistic approach to how battery calorimeters can be applied all along the battery value chain.
Manager EU Research at Centexbel, Guy Buyle introduces REMADYL, a H2020 project focused on the removal of legacy substances from PVC via a continuous and sustainable extrusion process.
Francesco Crivelli, PhD from CSEM Center Alpnach in Switzerland, discusses the automated 3D inspection of micro-electro-mechanical systems in this robotics & machine learning focus.
This chemistry focus delves into making nanocellulose filters for water purification with underutilised biomass, as described here by Benjamin Hsiao from Stony Brook University in the U.S.
Professor Heather Sheardown, leader of Innovation Hub C20/20, discusses their research, innovation, and development of new biomaterials-based technologies to treat a variety of disorders in the eye.
Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.
Neil Osheroff from the Vanderbilt University School of Medicine is working to overcome drug resistance and revitalise the use of established targets for antibacterial agents, as we discover here.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, shares a vision for remote decentralised clinical trials.
